Charles Schwab Investment Management »

Larimar Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $820k 125k 6.55
2024-06-30 $929k 128k 7.25
2024-03-31 $630k 83k 7.59
2023-12-31 $336k 74k 4.55
2023-09-30 $291k 74k 3.95
2023-06-30 $231k 74k 3.13
2023-03-31 $69k 15k 4.53
2022-12-31 $63k 15k 4.13